Remote Outcomes with Poly-ε-Caprolactone Aortic Grafts in Rats

Anna A Dokuchaeva1, Aleksandra B Mochalova1, Tatyana P Timchenko1

  • 1Institute of Experimental Biology and Medicine, E. Meshalkin National Medical Research Center of the RF Ministry of Health, 15 Rechkunovskaya St., Novosibirsk 630055, Russia.

Polymers
|November 14, 2023
PubMed
Summary

Poly-ε-caprolactone (PCL) vascular grafts remained patent in rats for 180 days, showing good revitalization but risks of mineralization and intimal hyperplasia.

Related Concept Videos